Skip to main content

Pro-Bac 4 + IBRk & BVDk

This page contains information on Pro-Bac 4 + IBRk & BVDk for veterinary use.
The information provided typically includes the following:
  • Pro-Bac 4 + IBRk & BVDk Indications
  • Warnings and cautions for Pro-Bac 4 + IBRk & BVDk
  • Direction and dosage information for Pro-Bac 4 + IBRk & BVDk

Pro-Bac 4 + IBRk & BVDk

This treatment applies to the following species:
Company: Bimeda Biologicals

Bovine Rhinotracheitis-Virus Diarrhea Vaccine, Killed Virus, Haemophilus Somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid

with REVEAL ATS™*

Cattle Vaccine

For Animal Use Only

Pro-Bac 4 + IBRk & BVDk Indications

This product has been shown to be effective for the vaccination of healthy cattle three months of age or older against Infectious Bovine Rhinotracheitis, Bovine Viral Diarrhea Type 1, Haemophilus Somnus, Mannheimia Haemolytica Type A-1, Mannheimia Haemolytica Type A-6 and Pasteurella Multocida Type A-3. Duration of immunity has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

This product contains inactivated Mannheimia Haemolytica leukotoxin and cell-associated antigens.

Directions For Use

Mix well and aseptically inject 2.0 mL dose subcutaneously in the side of the neck. Give a second dose 14 days after the first on the opposite side of the neck.

If severe exposure to IBR and/or BVD is anticipated, consideration should be given to re- vaccination with modified-live IBR and/or BVD vaccine.

Cautions: Do not mix with other products. May cause local swelling. Do not inject into muscle, may cause carcass trim. Do not vaccinate within 60 days of slaughter. Do not contaminate with dirt or chemicals. Use sterile equipment and adequately clean and disinfect bottle cap prior to each entry. Use entire contents when opened. Store at 2° to 8° C. Do not use if emulsion is broken as indicated by separation at the BOTTOM of bottle. In case of human exposure, contact a physician. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. This product has not been tested in pregnant animals.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

*Adjuvant - Bimeda Biological’s Proprietary Technology.

VLN / PCN: 290 / 4355.20

Bimeda Biologicals, Inc., San Angelo, Texas

(800) 284-8403

50 Dose / 100 mL, 100 Dose / 200 mL

CPN: 2090003.0

BIMEDA BIOLOGICALS, INC.
1702 NORTH BELL STREET, SAN ANGELO, TX, 76903
Telephone:   325-653-4505
Toll-Free:   800-284-8403
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2022-06-01